SCHEMBL26435404

SCHEMBL26435404

c1ccc2c(c1)cc(-c1ccc(-c3nc(-c4ccc5sc6ccccc6c5c4)nc(-c4cccc5ccc6ccccc6c45)n3)cc1)c1ccccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
HIF1A Q16665 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP11B1 P15538 1/20 0.33
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP1A2 P05177 2/20 0.31
ERBB2 P04626 1/20 0.31
FYN P06241 1/20 0.31
MAOA P21397 1/20 0.31
ACHE P22303 1/20 0.31
AHR P35869 1/20 0.31
GPR3 P46089 1/20 0.31
F9 P00740 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435703 0.96 L3MBTL1 (0.34) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL26435385 0.95 ALDH1A1 (0.35) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL26435374 0.93 ALDH1A1 (0.34) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL26435452 0.91 ALDH1A1 (0.35) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL24473202 0.90 F9 (0.36) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL26435406 0.90 F9 (0.36) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL26435376 0.90 PIM3 (0.37) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL26435375 0.90 ALOX5 (0.36) L3MBTL1ALDH1A1HPGDTSHRMAPK1
SCHEMBL26435398 0.89 ALOX5 (0.45) L3MBTL1NQO1NQO2ALOX5CYP1A2
SCHEMBL26435330 0.89 ALDH1A1 (0.35) L3MBTL1ALDH1A1HPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 L3MBTL1 1536/4885ALDH1A1 1532/4885HPGD 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.